The Impact of Nutritional Optimization to Enhance Postoperative Outcomes Using the R-Support Supplements
Launched by UNIVERSITAIR ZIEKENHUIS BRUSSEL · Sep 16, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how special nutritional supplements, called R-Support, might help patients recover better after certain surgeries, like tummy tucks, breast reductions, and body contouring. The study will take place in Belgium and the Netherlands and will include 200 patients aged 18 to 65 who are generally healthy. Participants will be randomly divided into two groups; one will receive the R-Support supplements for 14 days before and 14 days after their surgery, while the other group will not receive any supplements.
Patients in the study will be closely monitored for 8 weeks to see how quickly they recover, both physically and emotionally. The researchers will look at how long patients stay in the hospital and if there are any complications, like infections. This trial aims to find out if better nutrition before and after surgery can lead to quicker recoveries and fewer problems after surgery. If you’re a healthy adult planning to undergo one of the specified surgeries, you may be eligible to participate, but some health conditions and factors, such as smoking or certain medications, could exclude you from the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASAI\&II
- • Age 18-65
- * Type of surgery:
- • Abdominoplasty o Breast reduction
- • Breast reconstruction through a DIEaP-flap
- • Extensive circumferential liposuction and body contouring surgery
- Exclusion Criteria:
- * Patients with systemic illness, including:
- • Diabetes
- • Immune deficiencies
- • Severe cardiovascular disease
- • Renal insufficiency
- • Active smokers or smokers that didn't quit 4 weeks prior to surgery
- • Patients under chemotherapy (Patients currently undergoing chemotherapy are not allowed to participate in this study. Patient undergoing previous chemotherapy are allowed to participate in this study, as long as the chemotherapy ended 6 months before the planned surgery and are currently in remission or free of disease.)
- • Patients after bariatric surgery with partial or complete stomachresection
- • Patients taking SSRI medication
- • Pregnancy
- • ASAIII\&IV
- • Gluten intolerance
- • Lactose intolerance
- • Allergy or hypersensitivity to fish, soya, milk, shellfish.
About Universitair Ziekenhuis Brussel
Universitair Ziekenhuis Brussel (UZ Brussel) is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution affiliated with the Vrije Universiteit Brussel, UZ Brussel integrates cutting-edge medical research with high-quality patient care. The hospital's multidisciplinary teams are dedicated to exploring novel therapeutic approaches and contributing to the development of evidence-based treatments, ensuring the highest standards of safety and efficacy in clinical research. With a strong focus on collaboration and knowledge dissemination, UZ Brussel plays a pivotal role in shaping the future of medicine and improving patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported